Pancreatic Cancer Research

ResearcherIuliu Hațieganu University of Medicine and PharmacyActive in the last 2 years

Ioana Berindan‐Neagoe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-5828-1325; OpenAlex author ID A5064374408. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. The road to overcome pancreatic cancer: Where are we? Last author DOI 10.1016/j.heliyon.2024.e38196↗
  2. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection. Co-author DOI 10.3390/jcm9082440↗
  3. Molecular angiogenesis profile as a tool to discriminate chronic pancreatitis (CP) from pancreatic cancer (PC). Co-author DOI 10.1097/mpa.0b013e318205e347↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alexandru Tirpe · 1 shared paper, 2024 · strength 0.28
  2. Jan Hlavsa · 1 shared paper, 2020 · strength 0.10
  3. Natalia Gabło · 1 shared paper, 2020 · strength 0.10
  4. Vladimír Procházka · 1 shared paper, 2020 · strength 0.10
  5. Martin Loveček · 1 shared paper, 2020 · strength 0.10
  6. Ondřej Slabý · 1 shared paper, 2020 · strength 0.10
  7. Zdeněk Kala · 1 shared paper, 2020 · strength 0.10
  8. Igor Kišš · 1 shared paper, 2020 · strength 0.10
  9. Claudia Cristina Burz · 1 shared paper, 2011 · strength 0.03
  10. Andrada Seicean · 1 shared paper, 2011 · strength 0.03
  11. Alexandru Irimie · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.